<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007395.ref011">
 <label>11</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pascual-Salcedo</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Plasencia</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Ramiro</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Nuño</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Bonilla</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Nagore</surname>
   <given-names>D</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis</article-title>. 
  <source>Rheumatology (Oxford)</source>. 
  <year>2011</year>;
  <volume>50</volume>: 
  <fpage>1445</fpage>–
  <lpage>52</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/rheumatology/ker124" xmlns:xlink="http://www.w3.org/1999/xlink">10.1093/rheumatology/ker124</ext-link>
  <?supplied-pmid 21427177?>
  <pub-id pub-id-type="pmid">21427177</pub-id>
 </mixed-citation>
</ref>
